Stocks
Corcept Therapeutics Incorporated (CORT) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 128.0 | 113.9 | 108.3 | 138.3 | 68.4 | -6.79 | ||
| Changes by years, y/y, % | -2% | -11% | -5% | +28% | -51% | -12.1% | |||
Corcept Therapeutics Incorporated. EBITDA US GAAP, bln rub
Corcept Therapeutics Incorporated. EBITDA US GAAP, changes, %
Corcept Therapeutics Incorporated. EBITDA US GAAP, sum by quarters, bln rub
Corcept Therapeutics Incorporated (CORT) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 3.88 | 32.2 | 15.7 | 10.4 | -44.7 | -6.79 | |
| Changes by years, y/y, % | -87% | -23% | -67% | -60% | -1 253% | |||
| Changes by quarters, q/q, % | -85% | +729% | -51% | -34% | -530% | |||
